🇩🇪·Jan 1, 1970Industry
ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus in Advanced GEP-NETs
Publisher
I
ITM (Isotope Technologies Munich)
Germany
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ITM (Isotope Technologies Munich)
- Region
- Germany
- Scope
- Industry
- Published
- January 1, 1970
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on itm-radiopharma.com
Leave the platform to read the original full article on the publisher site.
Source: ITM (Isotope Technologies Munich)
Scope: Industry
Related coverage
More related coverage
Roche Newsroom/9h ago
Roche introduces cobas Hepatitis D Virus (HDV) test, the first fully automated diagnostic solution to identify the most severe form of viral hepatitis
openFDA Drug Labels/Jul 15
Drug label update: Acetaminophen Extra Strength
Official structured record identifier: 9d34abc2-3a9a-b68f-80d4-4ede1eb1e45f.
openFDA Drug Labels/Jul 15
Drug label update: Allergy Relief
Official structured record identifier: 44da36d2-1881-e779-d3a2-13ea828f9240.
Universitätsklinikum Erlangen/3h ago